Rifampin use | Non-survivors | Survivors | p Value | ||
---|---|---|---|---|---|
Entire population | n=23 | n=134 | |||
Rifampin during hospitalization | 2/23 | 8.7 % | 30/134 | 22.4 % | NS |
Rifampin during first 48 h of hospitalization | 1/23 | 4.3 % | 23/134 | 17.2 % | NS |
Rifampin during first 24 h of hospitalization | 0/23 | 0.0 % | 19/134 | 14.2 % | 0.078 |
Streptococcus pneumoniae meningitis | n=18 | n=58 | |||
Rifampin during hospitalization | 2/18 | 11.1 % | 18/58 | 31.0 % | NS |
Rifampin during first 48 h of hospitalization | 1/18 | 5.6 % | 15/58 | 25.9 % | 0.097 |
Rifampin during first 24 h of hospitalization | 0/18 | 0.0 % | 13/58 | 22.4 % | 0.031 |